Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 897-905 , November 2007

Quantitative analysis of [99mTc]C2A-GST distribution in the area at risk after myocardial ischemia and reperfusion using a compartmental model

  • Said Audi

      Affiliations

    • Department of Biomedical Engineering, Marquette University, Milwaukee, WI, USA
    • ,
  • Michael Poellmann

      Affiliations

    • Department of Biomedical Engineering, Marquette University, Milwaukee, WI, USA
    • ,
  • Xiaoguang Zhu

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    • ,
  • Zhixin Li

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    • ,
  • Ming Zhao

      Affiliations

    • Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 414 456 4059; fax: +1 414 456 6512.

Received 30 March 2007 ,Revised 17 June 2007 ,Accepted 25 June 2007.

References 

  1. Kostin S, Pool L, Elsasser A, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res. 2003;92:715–724
  2. Freude B, Masters TN, Kostin S, et al. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol. 1998;93:85–89
  3. Moens AL, Claeys MJ, Timmermans JP, Vrints CJ. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol. 2005;100:179–190
  4. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–257
  5. Song Z, Steller H. Death by design: mechanism and control of apoptosis. Trends Cell Biol. 1999;9:M49–M52
  6. Wyllie AH. Apoptosis: an overview. Br Med Bull. 1997;53:451–465
  7. Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol. 2000;10:649–655
  8. Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94:695–698
  9. Williamson P, Schlegel RA. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim Biophys Acta. 2002;1585:53–63
  10. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207–2216
  11. Post JA, Langer GA, Op den Kamp JAF, Verkleij AJ. Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and ‘gas-dissected’ membranes. Biochim Biophys Acta. 1998;943:256–266
  12. Wheeldon LW, Schumert Z, Turner DA. Lipid composition of heart muscle homogenate. J Lipid Res. 1965;6:481–489
  13. Blankenberg FG, Katsikis PD, Tait JF, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349–6354
  14. Zhao M, Beauregard DA, Loizou L, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med. 2001;7:1241–1244
  15. Petrovsky A, Schellenberger E, Josephson L, et al. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 2003;63:1936–1942
  16. Lahorte CMM, VanderHeyden JL, Steinmetz N, et al. Apoptosis-detecting radioligands: current state of the art and future perspectives. Eur J Nucl Med. 2004;31:887–919
  17. Tait JF, Smith C, Blankenberg FG. Structural requirements for in vivo detection of cell death with 99mTc-Annexin V. J Nucl Med. 2005;46:807–815
  18. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209–212
  19. Jung HI, Kettunen MI, Davletov B, et al. Detection of apoptosis using the C2A domain of synaptotagmin I. Bioconjug Chem. 2004;15:983–987
  20. Zhao M, Zhu X, Ji S, et al. 99mTc labeled C2A domain of Synaptotagmin I as a target-specific molecular probe for the non-invasive imaging of acute myocardial infarction. J Nucl Med. 2006;47:1367–1374
  21. Zhu X, Li Z, Zhao M. Imaging acute cardiac cell death — temporal and spatial distribution of 99mTc labeled C2A in the area-at-risk after myocardial ischemia and reperfusion. J Nucl Med. 2007;48:1031–1036
  22. Huber R, Romisch J, Paques EP. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J. 1990;9:3867–3874
  23. Zhang X, Rizo J, Sudhof TC. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I. Biochemistry. 1998;37:12395–12403
  24. Sutton RB, Davletov BA, Berghuis AM, Sudhof TC, Sprang SR. Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell. 1995;80:929–938
  25. Post JA, Langer GA, Op den Kamp JAF, Verkleij AJ. Phospholipid asymmetry in cardiac sarcolemma. Analysis of intact cells and ‘gas-dissected’ membranes. Biochim Biophys Acta. 1998;943:256–266
  26. Wheeldon LW, Schumert Z, Turner DA. Lipid composition of heart muscle homogenate. J Lipid Res. 1965;6:481–489
  27. Luckcuck T, Trotter PJ, Walker JH. Localization of annexin V in the adult and neonatal heart. Biochem Biophys Res Comm. 1997;238:622–628
  28. Pula G, Bianchi R, Ceccarelli P, Giambanco I, Donato R. Characterization of mammalian heart annexins with special reference to CaBP33 (annexin V). FEBS Lett. 1990;277:53–58
  29. Spreca A, Rambotti MG, Giambanco I, Pula G, Bianchi R, Ceccarelli P, et al. Immunocytochemical localization of annexin V (CaBP33), a Ca(2+)-dependent phospholipid- and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart. J Cell Physiol. 1992;152:587–598
  30. Doubell AF, Lazure C, Charbonneau C, Thibault G. Identification and immunolocalisation of annexins V and VI, the major cardiac annexins, in rat heart. Cardiovasc Res. 1993;27:1359–1367
  31. Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, et al. Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med. 2004;45:1536–1541
  32. Landaw EM, DiStefano JJ. Multiexponential, multicompartmental, and oncompartmental modeling: II. Data analysis and statistical considerations. Am J Physiol. 1984;246:R665–R677

PII: S0969-8051(07)00174-6

doi: 10.1016/j.nucmedbio.2007.06.009

Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 897-905 , November 2007

Article Tools

* Image Usage & Resolution